scispace - formally typeset
M

Maxim V. Kuleshov

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  18
Citations -  7780

Maxim V. Kuleshov is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Computer science & Gene. The author has an hindex of 8, co-authored 15 publications receiving 4402 citations. Previous affiliations of Maxim V. Kuleshov include Mount Sinai Health System.

Papers
More filters
Journal ArticleDOI

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

TL;DR: A significant update to one of the tools in this domain called Enrichr, a comprehensive resource for curated gene sets and a search engine that accumulates biological knowledge for further biological discoveries is presented.
Journal ArticleDOI

Gene Set Knowledge Discovery with Enrichr.

TL;DR: Enrichr as discussed by the authors is a gene set search engine that enables the querying of hundreds of thousands of annotated gene sets Enrichr uniquely integrates knowledge from many high-profile projects to provide synthesized information about mammalian genes and gene sets.
Journal ArticleDOI

The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations

Alexandra B Keenan, +107 more
- 29 Nov 2017 - 
TL;DR: The LINCS program focuses on cellular physiology shared among tissues and cell types relevant to an array of diseases, including cancer, heart disease, and neurodegenerative disorders.
Journal ArticleDOI

eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks.

TL;DR: X2K Web is a new implementation of the original eXpression2Kinases algorithm with important enhancements, and includes many new transcription factor and kinase libraries, and PPI networks.
Journal ArticleDOI

The COVID-19 Drug and Gene Set Library.

TL;DR: The COVID-19 Drug and Gene Set Library can be used to identify community consensus, make researchers and clinicians aware of new potential therapies, enable machine-learning applications, and facilitate the research community to work together toward a cure.